title: Full-mouth rehabilitation using dental implants in a patient with scleroderma.
abstract: Scleroderma is an autoimmune multisystem rheumatic condition that affects connective tissues. Oral manifestations of the disease are directly relevant to the dental and periodontal diagnosis, treatment plan, and management of patients diagnosed with scleroderma. In the presented case, progressive limitation of mouth opening together with severe caries and periodontal disease warranted a fixed implant-supported rehabilitation using dental implants. Three-year follow-up revealed good oral hygiene and clinical appearance with no radiologic evidence of bone loss around the implants. Implant-supported rehabilitation might be a viable treatment option in patients with scleroderma under chronic use of systemic steroids. Further studies with long-term follow-up are warranted.
authors: Department of Periodontology, School of Graduate Dentistry, Rambam Health Care Campus, Haifa, Israel.
authors: Hadar
authors: H
authors: Zigdon
authors: Zvi
authors: Z
authors: Gutmacher
authors: Sorin
authors: S
authors: Teich
authors: Liran
authors: L
authors: Levin
mesh_terms: D016301:Alveolar Bone Loss / Q000209:etiology; D003731:Dental Caries / Q000209:etiology; D003758:Dental Implantation, Endosseous; D015921:Dental Implants; D019094:Dental Prosthesis, Implant-Supported; D003779:Denture Design; D003824:Denture, Complete; D004955:Esthetics, Dental; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009065:Mouth Rehabilitation; D009910:Oral Hygiene; D010510:Periodontal Diseases / Q000209:etiology; D012595:Scleroderma, Systemic / Q000150:complications* / Q000188:drug therapy; D013256:Steroids / Q000627:therapeutic use; D014081:Tooth Extraction
chemical_list: D015921:Dental Implants; D007166:Immunosuppressive Agents; D013256:Steroids; D008727:Methotrexate